BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2004

View Archived Issues

First phase I/II data on the efficacy and safety of HuMax-CD20 in follicular lymphoma

Read More

TLK-199 shows promise in the treatment of MDS

Read More

New phase I data on the antitumor effects and safety of talabostat

Read More

Preclinical studies support the use of AQ4N to treat lymphoproliferative diseases

Read More

Update on the pharmacokinetics of erlosamide in healthy volunteers

Read More

NFkappaB-selective estrogen receptor ligand promising against rheumatoid arthritis

Read More

Plasmin-specific inhibitor shows potent antiinvasive and antiangiogenic effects in vitro

Read More

Triad Therapeutics sells p38 kinase inhibitor program to Novartis

Read More

Specific myosin activator may be useful for treatment of heart failure

Read More

Phase II glioblastoma multiforme study for 131I-TM-601

Read More

Tapestry advances development of lead oncolytic drugs

Read More

Pilot pharmacokinetic study for zolpidem lingual spray formulation

Read More

RxGen awarded phase I of fast track SBIR grant for Parkinson's research

Read More

Enrollment completed in phase III colonoscopy study of INKP-102

Read More

New prostaglandin I2 receptor antagonists in early development at Roche

Read More

Boehringer Ingelheim scientists report agents for the treatment of hepatitis C infection

Read More

Wyeth researchers develop an antibiotic from Micromonospora

Read More

Roche patent covers novel adenosine receptor modulators for Alzheimer's, Parkinson's, etc.

Read More

New adenosine receptor antagonists and their use described in Fujisawa patent

Read More

New treatments for Parkinson's disease claimed in Schering patent

Read More

Enrollment completed in first pivotal study of milnacipran for FMS

Read More

European marketing of Alvesco to commence in 2005

Read More

Positive findings from Bentley's phase II study of intranasal insulin in diabetics

Read More

PHX-1149 scheduled to enter clinic for type 2 diabetes in 2005

Read More

Phase IIa study of PA-457 in HIV patients

Read More

FTC requests extension for review of MDX-010 collaboration

Read More

Aventis spins off Novexel

Read More

PEG-Intron available in Japan in combination with Rebetol for HCV

Read More

Teikoku Hormone and Grelan Pharmaceutical to merge

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing